Physician profile
Brian Affleck
NPI 1386633824
$4,719.47
in general payments reported to CMS, 2019-2025
12 companies · $48.83 in 2025
The $48.83 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $683 · 2020: $525 · 2021: $820 · 2022: $2,532 · 2023: $55.11 · 2024: $54.67 · 2025: $48.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $158.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $3,325.11 | 2019-2025 | Inspire |
| Stryker Corporation | $990.74 | 2019-2025 | Na, Vsp System, Vsp Cranial |
| Regeneron Healthcare Solutions, INC. | $148.09 | 2021 | |
| Cochlear Americas | $63.66 | 2020-2021 | |
| Intersect Ent, INC. | $53.88 | 2019-2022 | |
| Aerin Medical INC. | $26.64 | 2022 | |
| Kls-Martin L.P. | $24.48 | 2020 | |
| Livanova USA, INC. | $24.46 | 2020 | |
| Arrinex, INC. | $16.93 | 2019 | |
| Glaxosmithkline, LLC. | $16.16 | 2021 | |
| Heron Therapeutics, INC. | $16.06 | 2021 | |
| Ambu INC. | $13.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Affleck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.